ZA202005507B - 10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1 ',2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza - Google Patents

10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1 ',2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza

Info

Publication number
ZA202005507B
ZA202005507B ZA2020/05507A ZA202005507A ZA202005507B ZA 202005507 B ZA202005507 B ZA 202005507B ZA 2020/05507 A ZA2020/05507 A ZA 2020/05507A ZA 202005507 A ZA202005507 A ZA 202005507A ZA 202005507 B ZA202005507 B ZA 202005507B
Authority
ZA
South Africa
Prior art keywords
pyrazino
pyrrolo
pyridazine
tetrahydro
hydroxy
Prior art date
Application number
ZA2020/05507A
Inventor
Maxime Dauphinais
Rama Jain
Dennis Christofer Koester
James R Manning
Vanessa Marx
Daniel Poon
Lifeng Wan
Xiaojing Michael Wang
Aregahegn Yifru
Qian Zhao
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA202005507B publication Critical patent/ZA202005507B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present disclosure refers to 10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7H-pyrrolo[1';2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds of Formula (A) as inhibitors of the orthomyxovirus replication for treating influenza. A preferred specific compound is e.g. (9aR,10S)-10-((S)-(4-fluorophenyl)(3-(trifluoromethyl)phenyl)methyl)-4-hydroxy-8,9,9a,10- tetrahydro-7H-pyrrolo[1';2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione (example 1).
ZA2020/05507A 2018-02-28 2020-09-03 10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1 ',2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza ZA202005507B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862636378P 2018-02-28 2018-02-28
PCT/IB2019/051549 WO2019166950A1 (en) 2018-02-28 2019-02-26 10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1 ',2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza

Publications (1)

Publication Number Publication Date
ZA202005507B true ZA202005507B (en) 2025-03-26

Family

ID=65911219

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2020/05507A ZA202005507B (en) 2018-02-28 2020-09-03 10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1 ',2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza

Country Status (31)

Country Link
US (3) US11629149B2 (en)
EP (2) EP4467198A3 (en)
JP (4) JP7065989B2 (en)
KR (3) KR102521320B1 (en)
CN (2) CN111801333B (en)
AU (1) AU2019227250B2 (en)
BR (1) BR112020017121A2 (en)
CA (1) CA3092544A1 (en)
CL (1) CL2020002202A1 (en)
CR (2) CR20200372A (en)
DK (1) DK3759113T3 (en)
EA (1) EA202091696A1 (en)
ES (1) ES2993277T3 (en)
FI (1) FI3759113T3 (en)
HR (1) HRP20241522T1 (en)
HU (1) HUE069183T2 (en)
IL (3) IL276901B2 (en)
LT (1) LT3759113T (en)
MX (2) MX2020008959A (en)
MY (1) MY203207A (en)
NZ (1) NZ767072A (en)
PE (1) PE20210403A1 (en)
PH (1) PH12020500660A1 (en)
PL (1) PL3759113T3 (en)
PT (1) PT3759113T (en)
SA (1) SA520420046B1 (en)
SG (1) SG11202007718SA (en)
SI (1) SI3759113T1 (en)
UA (1) UA126253C2 (en)
WO (1) WO2019166950A1 (en)
ZA (1) ZA202005507B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2881776T3 (en) 2016-03-08 2021-11-30 Novartis Ag Tricyclic compounds useful for treating orthomyxovirus infections
JOP20170169A1 (en) 2016-08-29 2019-01-30 Novartis Ag Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
HUE069183T2 (en) * 2018-02-28 2025-02-28 Novartis Ag 10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1',2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2225112A (en) 1938-07-09 1940-12-17 Wright Aeronautical Corp Air cleaner
GB8501542D0 (en) 1985-01-22 1985-02-20 Erba Farmitalia 4 5 6 7-tetrahydro-imidazo(4 5-clpyridine derivatives
AUPM354694A0 (en) 1994-01-27 1994-02-17 Biota Scientific Management Pty Ltd Chemical compounds
ATE530520T1 (en) 2001-08-10 2011-11-15 Shionogi & Co ANTIVIRAL AGENT
WO2004078163A2 (en) 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
TW200510425A (en) 2003-08-13 2005-03-16 Japan Tobacco Inc Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
TW200526635A (en) 2003-12-22 2005-08-16 Shionogi & Co Hydroxypyrimidinone derivative having HIV integrase inhibitory activity
AU2005221864A1 (en) 2004-03-09 2005-09-22 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa HIV integrase inhibitors
FR2901795A1 (en) 2006-05-30 2007-12-07 Fourtillan Snc DERIVATIVES OF PYRIMIDINO [1 ', 6'-1,2] PYRIDO [3,4-B] INDOLES AND THEIR USE IN THERAPEUTICS
EA019520B1 (en) 2008-10-31 2014-04-30 Сионоги Энд Ко., Лтд. CEFALOSPORINS, CONTAINING CATEGHOLIC GROUP
TWI518084B (en) 2009-03-26 2016-01-21 鹽野義製藥股份有限公司 Process for pyrone and pyridone derivatives
US8835461B2 (en) 2009-03-26 2014-09-16 Shionogi & Co., Ltd. Substituted 3-hydroxy-4-pyridone derivative
JP5737691B2 (en) * 2009-06-15 2015-06-17 塩野義製薬株式会社 Substituted polycyclic carbamoylpyridone derivatives
CN102762568A (en) 2009-12-23 2012-10-31 伊兰药品公司 Pteridinones as inhibitors of polo - like kinase
TW201201813A (en) 2010-03-31 2012-01-16 Arqule Inc Substituted benzo-pyrido-triazolo-diazepine compounds
US20120195857A1 (en) 2010-08-12 2012-08-02 Bristol-Myers Squibb Company Hepatitis C Virus Inhibitors
LT2620436T (en) 2010-09-24 2018-08-10 Shionogi & Co., Ltd. Substituted polycyclic carbamoyl pyridone derivative prodrug
WO2012151567A1 (en) 2011-05-05 2012-11-08 St. Jude Children's Research Hospital Pyrimidinone compounds and methods for preventing and treating influenza
AU2012321762A1 (en) 2011-10-12 2014-04-17 Shionogi & Co., Ltd. Polycyclic pyridone derivative having integrase-inhibiting activity
US9278996B2 (en) 2012-09-20 2016-03-08 Celltrion, Inc. Dolastatin-10 derivative, method of producing the same and anticancer drug composition containing the same
EA201591291A1 (en) 2013-01-08 2015-12-30 Савира Фармасьютикалз Гмбх DERIVATIVES OF PYRIMIDON AND THEIR APPLICATION IN TREATMENT, FACILITATION OR PREVENTION OF VIRAL DISEASE
CA2921294C (en) 2013-08-21 2023-05-16 Alios Biopharma, Inc. Antiviral compounds
CN105530946A (en) 2013-09-11 2016-04-27 南加利福尼亚大学 Stem cell compositions with highly expressed FAS ligand
CN105764904B (en) 2013-09-12 2020-02-11 詹森生物制药有限公司 Aza-pyridone compounds and uses thereof
AU2014318837B2 (en) 2013-09-12 2019-05-30 Janssen Biopharma, Inc. Pyridazinone compounds and uses thereof
CA2953862A1 (en) 2014-07-07 2016-01-14 F. Hoffmann-La Roche Ag Dihydropyridopyrazine-1,8-diones and their use in the treatment, amelioration or prevention of viral diseases
WO2016145103A1 (en) * 2015-03-11 2016-09-15 Alios Biopharma, Inc. Aza-pyridone compounds and uses thereof
ES2881776T3 (en) 2016-03-08 2021-11-30 Novartis Ag Tricyclic compounds useful for treating orthomyxovirus infections
WO2017156407A1 (en) 2016-03-10 2017-09-14 Alios Biopharma, Inc. Method of preparing aza-pyridone compounds
WO2018005863A1 (en) 2016-07-01 2018-01-04 G1 Therapeutics, Inc. Pyrimidine-based compounds for the treatment of cancer
CN109789143A (en) 2016-07-01 2019-05-21 G1治疗公司 Antiproliferative based on pyrimidine
US10759814B2 (en) * 2016-08-10 2020-09-01 Shionogi & Co., Ltd. Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof
JOP20170169A1 (en) * 2016-08-29 2019-01-30 Novartis Ag Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
JP2019059697A (en) 2017-09-28 2019-04-18 塩野義製薬株式会社 Substituted polycyclic pyridazine derivatives and prodrugs thereof
CN110041327B (en) * 2018-01-17 2022-01-21 江西彩石医药科技有限公司 Pyridone derivative, composition thereof and application of pyridone derivative as anti-influenza virus medicament
CN111848615B (en) 2018-01-17 2022-05-17 江西彩石医药科技有限公司 Pyridone derivatives and anti-influenza virus pharmaceutical compositions containing the same
KR20200126973A (en) 2018-02-28 2020-11-09 니뽄 다바코 산교 가부시키가이샤 4-methyldihydropyrimidinone compound and its pharmaceutical use
PE20211456A1 (en) 2018-02-28 2021-08-05 Hoffmann La Roche 7-SUBSTITUTED SULFONIMIDOYLPURINONE COMPOUNDS AND ITS DERIVATIVES FOR THE TREATMENT AND PREVENTION OF LIVER CANCER
CN111741948B (en) 2018-02-28 2023-11-10 日本烟草产业株式会社 Saturated ring fused dihydropyrimidinone or dihydrotriazinone compounds and their pharmaceutical uses
HUE069183T2 (en) 2018-02-28 2025-02-28 Novartis Ag 10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1',2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza

Also Published As

Publication number Publication date
IL305957B2 (en) 2026-07-01
CN118878544A (en) 2024-11-01
CL2020002202A1 (en) 2021-01-15
JP7065989B2 (en) 2022-05-12
US12071441B2 (en) 2024-08-27
WO2019166950A1 (en) 2019-09-06
US20230322793A1 (en) 2023-10-12
MX2020008959A (en) 2020-10-05
EP3759113B1 (en) 2024-09-11
EP4467198A3 (en) 2025-05-07
IL276901B2 (en) 2024-03-01
HRP20241522T1 (en) 2025-01-03
KR20230031990A (en) 2023-03-07
DK3759113T3 (en) 2024-10-28
US20200407366A1 (en) 2020-12-31
IL326515A (en) 2026-04-01
PT3759113T (en) 2024-11-25
EA202091696A1 (en) 2021-01-27
JP2022048391A (en) 2022-03-25
HUE069183T2 (en) 2025-02-28
EP3759113A1 (en) 2021-01-06
JP2024033009A (en) 2024-03-12
AU2019227250B2 (en) 2021-11-04
PH12020500660A1 (en) 2021-06-28
MY203207A (en) 2024-06-14
US11629149B2 (en) 2023-04-18
AU2019227250A1 (en) 2020-09-03
US20250034156A1 (en) 2025-01-30
BR112020017121A2 (en) 2020-12-22
CA3092544A1 (en) 2019-09-06
KR20240073143A (en) 2024-05-24
ES2993277T3 (en) 2024-12-26
JP2021514984A (en) 2021-06-17
CR20240350A (en) 2024-09-30
KR20200125654A (en) 2020-11-04
NZ767072A (en) 2024-03-22
PE20210403A1 (en) 2021-03-02
LT3759113T (en) 2024-11-11
UA126253C2 (en) 2022-09-07
IL276901A (en) 2020-10-29
CN111801333B (en) 2024-07-30
SG11202007718SA (en) 2020-09-29
KR102521320B1 (en) 2023-04-13
MX2023000084A (en) 2023-02-09
JP2026034569A (en) 2026-02-27
PL3759113T3 (en) 2025-01-20
SA520420046B1 (en) 2024-01-22
CN111801333A (en) 2020-10-20
CR20200372A (en) 2020-10-26
IL276901B1 (en) 2023-11-01
IL305957A (en) 2023-11-01
FI3759113T3 (en) 2024-11-01
IL305957B1 (en) 2026-03-01
SI3759113T1 (en) 2025-01-31
EP4467198A2 (en) 2024-11-27

Similar Documents

Publication Publication Date Title
SA522433155B1 (en) Trisubstituted ring compounds
PH12022551014A1 (en) Substituted tricyclic compounds
MX2007007103A (en) Spiro derivatives as lipoxygenase inhibitors.
EP4365179A3 (en) Novel rapamycin derivatives
WO2020097400A8 (en) Imidazopyridine derivatives and aza-imidazopyridine derivatives as janus kinase 2 inhibitors and uses thereof
PH12020500660A1 (en) 10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1 `,2`:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
NZ630719A (en) Imidazo [1, 2 - b] pyridazine - based compounds, compositions comprising them, and uses thereof
MX2012015098A (en) Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors.
EA201592252A1 (en) 6,7-DIHYDROPYRAZOLO [1,5-a] PYRAZIN-4 (5H) -ONE COMPOUNDS AND THEIR APPLICATION AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
PH12020550168A1 (en) Griseofulvin compound and pharmaceutical use thereof
MX2021013576A (en) Compound used as kinase inhibitor and application thereof.
PH12020550761A1 (en) 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZINONE DERIVATIVE AND MEDICAL USE THEREOF
MY195576A (en) Novel Amino-Imidazopyridine Derivatives as Janus Kinase Inhibitors and Pharmaceutical use Thereof
MX2025002519A (en) Pyridazinon derivatives as kat2 degraders for the treatment of proliferative disorders
EA201991355A1 (en) IMIDAZO [1,5-A] PYRASINE DERIVATIVES AS PI3K DELTA INHIBITORS
MX379704B (en) 6,7-dihydro-5h-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds
DE60214401D1 (en) HETERO BICYCLIC CRF ANTAGONISTS
MX2024000999A (en) Lpa1 small molecule antagonist.
MY158069A (en) Tricyclic compound and pharmaceutical use thereof
TW200609218A (en) Bicyclic compounds
EA201691690A1 (en) DERIVATIVES OF ETHYNES
NZ764463A (en) Heterocyclic compound and application thereof in medicine
WO2008031771A3 (en) 3-azabicyclo [4. 1. 0] heptane derivatives for the treatment of depression
EA202090644A1 (en) IMIDAZO DERIVATIVES [1,5-a] PYRASINE AS PI3K INHIBITORS
MA39204A1 (en) Heteroaryl derivatives inhibiting vps34 and / or p13 for the treatment of proliferative, inflammatory or cardiovascular disorders